The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brigatinib (BRG) in patients (pts) with ALK+ non-small cell lung cancer (NSCLC): Updates from a phase 1/2 trial.
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Genoptix; Heat Biologics; Novartis; Pfizer; Trovagene
Speakers' Bureau - AstraZeneca; Genentech; Novartis; Pfizer
Research Funding - BeyondSpring Pharmaceuticals
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Incyte; Pfizer; Roche/Genentech
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Stem CentRx (Inst)
 
Ravi Salgia
No Relationships to Disclose
 
Kathryn A. Gold
Honoraria - Roche/Genentech
Consulting or Advisory Role - ARIAD
Research Funding - ARIAD; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Pharmacyclics; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca
 
Rafael Rosell
No Relationships to Disclose
 
Alice Tsang Shaw
Honoraria - Foundation medicine; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; KSQ Therapeutics; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech
 
Glen J. Weiss
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Blend Therapeutics; Paradigm; Pharmatech; Viomics
Speakers' Bureau - Medscape; Merck; Novartis
Travel, Accommodations, Expenses - NantWorks
 
Jeff Haney
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Victor M. Rivera
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
David Kerstein
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
D. Ross Camidge
Honoraria - ARIAD
Research Funding - ARIAD